Hristo Sabev, director of clinical management for PPD in Bulgaria, shares an interesting overview of clinical research in Bulgaria and highlights PPD’s commitment as one of the leading CROs in the country.
PPD has a quite unique footprint in the country due to the acquisition of AbCRO back in 2009. Can you briefly introduce to our international audience the history behind the affiliate’s operations?
"Based on our experience, the most prevalent disease types are within the oncology and cardiology therapeutic areas."
